Skip to content

Clinical trials

Dementia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Country / region: Germany Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20041
20051
20062
20071
20085
20091
20101
20114
20126
20138
20148
20155
20167
20176
20185
20193
20204
20212
20223
20232
20242
20257
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Terminated15
Recruiting13
Unknown status11
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
German Center for Neurodegenerative Diseases (DZNE)7
Charite University, Berlin, Germany6
AstraZeneca4
Washington University School of Medicine4
Novartis Pharmaceuticals3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
TauRx Therapeutics Ltd3
Technical University of Munich3
Avraham Pharmaceuticals Ltd2
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia88
Alzheimer Disease46
Cognitive Dysfunction26
Brain Diseases15
Neurodegenerative Diseases15
Mental Disorders13
Nervous System Diseases13
Central Nervous System Diseases10
Neurocognitive Disorders10
Dementia, Vascular7

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.